NUVB vs WRD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NUVB · Nuvation Bio$4.16 ▼ 0.72%
WRD · WeRide$4.46 ▲ 10.40%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NUVB -10.3%
- WRD -45.4%
Head to head
| Metric | NUVB | WRD |
|---|---|---|
| Price | $4.16 | $4.46 |
| Change today | ▼ 0.72% | ▲ 10.40% |
| Market cap | $1.47B | $1.47B |
| Return, 3 months | -37.0% | -29.4% |
| Return, year to date | -53.6% | -48.6% |
| Return, 1 year | -12.1% | -44.2% |
| P/E (TTM) | – | – |
| P/B | 6.4 | 1.5 |
| P/E percentile vs own 5y | 19th | 89th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +555.6% | +82.2% |
| Net profit growth (YoY) | -6.5% | +1.4% |
| Gross margin | 88.2% | 32.8% |
| Operating margin | -81.0% | -216.4% |
| Net margin | -88.2% | -199.0% |
| Return on equity | -47.8% | -25.7% |
| Analyst target vs. price | +250.2% | +191.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 31 | 48 |
| 30-day volatility | 56.2% | 69.8% |
| Max drawdown, 1 year | -57.5% | -65.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NUVB is the largest of the group by market value.
- NUVB has returned the most over the past year.
- NUVB is growing revenue fastest.
- NUVB keeps the most profit per dollar of sales.
- NUVB has been the calmest stock over the last 30 days.